145 related articles for article (PubMed ID: 35248424)
1. Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.
Abbatecola AM; Incalzi RA; Malara A; Palmieri A; Di Lonardo A; Fedele G; Stefanelli P; Borselli G; Russo M; Noale M; Fumagalli S; Gareri P; Mossello E; Trevisan C; Volpato S; Monzani F; Coin A; Bellelli G; Okoye C; Del Signore S; Zia G; Bottoni E; Cafariello C; Onder G;
Vaccine; 2022 Apr; 40(15):2324-2330. PubMed ID: 35248424
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study.
Trevisan C; Raparelli V; Malara A; Abbatecola AM; Noale M; Palmieri A; Fedele G; Di Lonardo A; Leone P; Schiavoni I; Stefanelli P; Volpato S; Antonelli Incalzi R; Onder G;
Intern Emerg Med; 2023 Aug; 18(5):1337-1347. PubMed ID: 37120663
[TBL] [Abstract][Full Text] [Related]
3. The association between frailty, long-term care home characteristics and COVID-19 mortality before and after SARS-CoV-2 vaccination: a retrospective cohort study.
Dash D; Mowbray FI; Poss JW; Aryal K; Stall NM; Hirdes JP; Hillmer MP; Heckman GA; Bowdish DME; Costa AP; Jones A
Age Ageing; 2023 Dec; 52(12):. PubMed ID: 38163287
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study.
Trevisan C; Haxhiaj L; Malara A; Abbatecola A; Fedele G; Palmieri A; Leone P; Schiavoni I; Stefanelli P; Maggi S; Sergi G; Volpato S; Incalzi RA; Onder G;
Drugs Aging; 2023 Dec; 40(12):1133-1141. PubMed ID: 37938521
[TBL] [Abstract][Full Text] [Related]
5. Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents.
Montejano-Hervás P; Gómez-Pavón J; Tornero-Torres O; Valverde-Moyar MV; Martín Cruz B; Vela Carbonera M; Fuentes-Irigoyen R; Tejada González P; González-Becerra M; Higueras Sánchez E; Ramos Cordero P
Drugs Aging; 2022 Jul; 39(7):587-595. PubMed ID: 35794430
[TBL] [Abstract][Full Text] [Related]
6. Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist.
Andrew MK; Schmader KE; Rockwood K; Clarke B; McElhaney JE
Clin Interv Aging; 2021; 16():731-738. PubMed ID: 33953551
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-term Care Facilities: Data From the GeroCovid Vax Study.
Virgilio E; Trevisan C; Abbatecola A; Malara A; Palmieri A; Fedele G; Stefanelli P; Leone P; Schiavoni I; Maggi S; Volpato S; Antonelli Incalzi R; Onder G;
Diabetes Care; 2022 Dec; 45(12):2935-2942. PubMed ID: 36201657
[TBL] [Abstract][Full Text] [Related]
9. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
[TBL] [Abstract][Full Text] [Related]
10. Humoral immunity induced by mRNA COVID-19 vaccines in Nursing Home Residents previously infected with SARS-CoV-2.
Fedele G; Palmieri A; Damiano C; Di Lonardo A; Leone P; Schiavoni I; Trevisan C; Abbatecola AM; Cafariello C; Malara A; Minchella P; Panduri G; Antonelli Incalzi R; Palamara AT; Stefanelli P; Onder G;
Aging Clin Exp Res; 2022 Oct; 34(10):2577-2584. PubMed ID: 36127623
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study.
Salmerón Ríos S; Mas Romero M; Cortés Zamora EB; Tabernero Sahuquillo MT; Romero Rizos L; Sánchez-Jurado PM; Sánchez-Nievas G; Señalada JJB; García Nogueras I; Estrella Cazalla JD; Andrés-Pretel F; Murillo Romero A; Lauschke VM; Stebbing J; Abizanda P
J Am Geriatr Soc; 2021 Jun; 69(6):1441-1447. PubMed ID: 33768521
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study.
Salmerón Ríos S; Cortés Zamora EB; Avendaño Céspedes A; Romero Rizos L; Sánchez-Jurado PM; Sánchez-Nievas G; Mas Romero M; Tabernero Sahuquillo MT; Blas Señalada JJ; Murillo Romero A; García Nogueras I; Estrella Cazalla JD; Andrés-Pretel F; Lauschke VM; Stebbing J; Abizanda P
J Am Geriatr Soc; 2022 Mar; 70(3):650-658. PubMed ID: 34894403
[TBL] [Abstract][Full Text] [Related]
14. Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Mor V
Vaccine; 2021 Jun; 39(29):3844-3851. PubMed ID: 34092431
[TBL] [Abstract][Full Text] [Related]
15. Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents - United States, October 31, 2022-May 7, 2023.
Haanschoten E; Dubendris H; Reses HE; Barbre K; Meng L; Benin A; Bell JM
MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(40):1095-1098. PubMed ID: 37796756
[TBL] [Abstract][Full Text] [Related]
16. Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Trigueros M; Pradenas E; Palacín D; Muñoz-López F; Ávila-Nieto C; Trinité B; Bonet-Simó JM; Isnard M; Moreno N; Marfil S; Rovirosa C; Puig T; Grau E; Chamorro A; Martinez A; Toledo R; Font M; Ara J; Carrillo J; Mateu L; Blanco J; Clotet B; Prat N; Massanella M;
Age Ageing; 2022 May; 51(5):. PubMed ID: 35595256
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada.
Fisman DN; Bogoch I; Lapointe-Shaw L; McCready J; Tuite AR
JAMA Netw Open; 2020 Jul; 3(7):e2015957. PubMed ID: 32697325
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
[TBL] [Abstract][Full Text] [Related]
19. Predictors of mortality among long-term care residents with SARS-CoV-2 infection.
Lee DS; Ma S; Chu A; Wang CX; Wang X; Austin PC; McAlister FA; Kalmady SV; Kapral MK; Kaul P; Ko DT; Rochon PA; Schull MJ; Rubin BB; Wang B;
J Am Geriatr Soc; 2021 Dec; 69(12):3377-3388. PubMed ID: 34409590
[TBL] [Abstract][Full Text] [Related]
20. Protecting Nursing Homes and Long-Term Care Facilities From COVID-19: A Rapid Review of International Evidence.
Dykgraaf SH; Matenge S; Desborough J; Sturgiss E; Dut G; Roberts L; McMillan A; Kidd M
J Am Med Dir Assoc; 2021 Oct; 22(10):1969-1988. PubMed ID: 34428466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
